Keeping Newly Public Biotechs Running Successfully

 

The record number of biotech companies that have gone public in recent times is not only impressive in terms of the amount of money these companies have made but also the vast number of firms that have managed to achieve public status. However, while getting public status is a hard road to navigate, keeping newly public biotechs successful and staying public can be an even bigger challenge!

Continue reading “Keeping Newly Public Biotechs Running Successfully”

The Glut of Funding Available When Biotech’s Choose to Go Public

 

The Glut of Funding Available When Biotech’s Choose to Go Public

At the end of 2020, many of us reflected on the huge successes that the Biotech industry had experienced with obtaining IPO funding; we did not expect to see it continue long into 2022. However, it has, and an astonishing number of Biotech firms are enjoying large amounts of funding when they take their company public.

Continue reading “The Glut of Funding Available When Biotech’s Choose to Go Public”

Keeping an Eye on Omicron – Where it May Lead in 2022

As the Omicron variant emerged, initial concerns arose regarding its potential impact compared to the Delta variant. Recent developments suggest it may pose even greater challenges. In this article, we explore the Omicron impact in 2022, evolving implications of the Omicron variant as it unfolds in the coming weeks.

Continue reading “Keeping an Eye on Omicron – Where it May Lead in 2022”

How to Handle a Growing Wave of Executive Retirements

The subject of retirement is often discussed by Life Science executives, especially with the ongoing pressure to offer more solutions and support to the global market. The concern that many of us face is the impact of this wave when people have left their positions and how the industry will cope with finding new people to replace them. Let’s take a look at some of the key reasons executives feel the need to leave and learn more about how we can help.

Continue reading “How to Handle a Growing Wave of Executive Retirements”

The Top Life Science Trends

There is no denying the fact that the Life Science industry is in high demand as we all look for improvements in our lives, wanting answers and solutions that can revolutionize our health. With that demand comes a world that is constantly changing and improving, but how can we work out where our focus needs to be and what is better left for the future? We took a look at some of the biggest trends in Life Science right now in a bid to work out where we are headed.

Continue reading “The Top Life Science Trends”

Why Property Developers and Investors Want to Work with Life Science Companies

The Life Science industry is facing more demand for information than ever before. Despite a global staffing shortage, more companies are looking to expand their offer to meet the need. COVID-19 has boosted the amount of research money available, leaving many Life Science companies in desperate need of more space, opening up the property investment market to find suitable premises for labs, manufacturing, and office space. Continue reading “Why Property Developers and Investors Want to Work with Life Science Companies”

Finding the Right Talent Without Compromising Your Workload

Finding the Right Talent Without Compromising Your Workload (1)

Working in the Life Science industry is both exciting and rewarding, but when you are given the challenge of finding the right talent in addition to your current role, then you can be left feeling alone and overwhelmed, especially with the ongoing shortages in the field. Worryingly, there is a growing trend in Life Science that someone who holds a senior post and undertakes extensive levels of work is considered the best person to be responsible for finding new talent.

Continue reading “Finding the Right Talent Without Compromising Your Workload”